← Back to Patent Explorer
US4352813A Expired / Lapsed US ⏱️ 0.0 years remaining

[(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine

Assignee: Angelini Acraf SpA
•
Filing: 1981-06-02
•
Granted: 1982-10-05
•
Expires: 2001-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid (or bendazac) with L. lysine. Following oral administrations of this compound in man, the concentrations of bendazac found in the blood are higher than those obtained after administration of bendazac as such. This discovery extends the therapeutic use of bendazac. In fact, whereas up to now bendazac could only be used topically, the L. lysine salt of bendazac makes it possible to perform therapeutic treatments with the oral route of administration as an agent with a normalizing effect on blood lipids.

Inventors

  • 👤 Bruno Silvestrini
  • 👤 Leandro Baiocchi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 05:30
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/54; C07D231/56; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415; A61P; A61P29/00; A61P3/00; A61P3/06

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 9 words
A salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid with L. lysine.
Claim 2
Dependent Claim 9 words
A salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid with L. lysine.
Claim 3
Dependent Claim 32 words
A pharmaceutical composition for use in the treatment of high blood lipids levels comprising an amount of the compound of claim 1 effective in said treatment together with a pharmaceutically acceptable carrier.
Claim 4
Dependent Claim 35 words
A method for the treatment of humans suffering from high blood lipid levels comprising orally administering to said human being an amount of the compound of claim 1 effective to decrease high blood lipid levels.

References Cited (Backward Citations)

FR1530097A Cited
US3470194A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-04 1986-04-05 1986-10-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-04 1990-04-05 1990-10-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-04 1994-04-05 1994-10-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag